Cancer observatory: an unprecedented study in Brazil, conducted by ACCamargo, collects oncological information from the last 20 years at the institute
A leader in scientific knowledge of oncology and an international reference center in oncology teaching, research and care, the ACCamargo Cancer Center recently launched the Cancer Observatory.
html[data-range=”xlarge”] figure image img.img-ebed3672ebaf4d65304a424ab49add768hd319tf { width: 774px; height: 516px; }HTML[data-range=”large”] figure image img.img-ebed3672ebaf4d65304a424ab49add768hd319tf { width: 548px; height: 365px; }HTML[data-range=”small”] figure figure img.img-ebed3672ebaf4d65304a424ab49add768hd319tf, html[data-range=”medium”] figure image img.img-ebed3672ebaf4d65304a424ab49add768hd319tf { width: 564px; height: 376px; }HTML[data-range=”small”] .article__image-embed, html[data-range=”medium”] .article__image-embed { width: 564px; margin: auto 0 30px; }
Unprecedented in the country, the document collects a series of information on 98,711 cancer cases diagnosed, treated and rehabilitated at ACCamargo between 2000 and 2020. Among other data, it contains descriptions of treatments, cancer staging and survival rates.
“One of the major contributions of the publication is the possibility of realizing the advances in overall survival rates in each of the types of cancers treated at ACCamargo over the past two decades, highlighting the advances in melanomas and lung cancer,” says Dr. Vittorio Piana, CEO of ACCamargo.
The information is also shared with the São Paulo Oncocentro Foundation (Fosp), the São Paulo Department of Health and the National Cancer Institute (INCA), to assist in the development of case estimates in the country. All data is validated by the Hospital Cancer Registry.
“Our professionals read medical records and write down information about the stage of the disease, treatments and the patient’s situation,” explains Dr. José Fregnani, Superintendent of Teaching and Research at ACCamargo. These medical records are essential for patient tracking.
According to the head of the Cancer Epidemiology and Statistics Group at the ACCamargo International Research Center, Dr. Maria Paula Curado, “this is the only way in which it is possible for hospitals to monitor operations and monitor the evolution of survival rates, especially in cases of advanced cancers, taking into account the patients’ quality of life”.
Longer Survival and Cancer Center Française |
The data published by the Cancer Observatory attest to the excellence in cancer treatment carried out by ACCamargo since its foundation in 1953. According to the document, the probability of overall five-year survival for the most frequent cancers, in both sexes, increased in the periods from 2000 to 2017.
Unlike general hospitals, ACCamargo is an Oncological Center, i.e. a health facility capable of satisfying all the health needs that cancer patients need in one place. This is why it has protocols for every type of tumor and hyper-specialised teams, divided into 12 Reference Centres, resources and state-of-the-art equipment.
Robotic surgery and global recognition
At the end of 2 0 2 2 , ACCamargo recorded more than 4,000 robotic oncology surgeries, making it one of the largest centers of this type of surgery in Latin America. “The advantage of this surgery is the precision of the movements, which cause less aggression to normal tissues, resulting in less trauma, easier anesthetic recovery and less blood consumption,” explains Dr. Flat.
With cutting-edge technology and an active teaching and research area with professionals recognized internationally for their expertise and scientific production, ACCamargo is a world reference in oncology and the largest private center of oncological scientific production in Brazil.
Another highlight of the institution is its pioneering role in the research and development of cutting-edge cancer treatments, such as immunotherapy to reprogram the body’s defense cells to act against cancer, known as CAR-T cells. The treatment was approved by Anvisa in 2022 and is considered a milestone of the new era of medicine – and ACCamargo is one of the cancer centers that most apply this immunotherapy in the world
Good news!
The Cancer Observatory demonstrates an increase in the probability of overall survival at 5 years for both sexes
Lung cancer
Men had an increase in survival from 10.4% (2000-2004) to 51.1% (2015-2017)
Women had an increase in survival from 18.8% (2000-2004) to 59% (2015-2017)
Stomach cancer
Men had an increase in overall survival from 25.2% (2000-2004) to 51.0% (2015-2017)
Women had an increase in survival from 31.3% (2000-2004) to 58.5% (2015-2017)
Source: Terra
Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.
